A vaccine that actually worked meant the world might eventually return to normal
On a Monday morning in São Paulo, the architecture of Brazilian interest rates quietly shifted — not because of anything decided in Brasília, but because of a scientific announcement made thousands of miles away. Moderna's report of 94.5% vaccine efficacy breathed possibility back into global markets, weakening the dollar and lifting the real, and traders responded by pricing in a future that looked, for the first time in months, a little less uncertain. It was a reminder that in interconnected economies, hope itself can move a yield curve.
- Moderna's 94.5% efficacy announcement sent a wave of optimism through global markets, instantly reshaping risk appetite from New York to São Paulo.
- Brazilian interest rate futures fell across all maturities by 9:08 a.m., with longer-dated contracts — those pricing in 2025 and 2027 — dropping the hardest as the real strengthened against the dollar.
- A complicating signal emerged: Brazil's IGP-10 inflation gauge for early November came in at 3.51%, above forecasts, raising quiet questions about whether wholesale price pressures would eventually reach consumers.
- Central Bank president Roberto Campos Neto's scheduled press conference — nominally about the new PIX payment system — was being watched for any signal on inflation, fiscal risk, and the trajectory of the Selic rate into 2021.
- Beneath the market moves, a political undercurrent: Bolsonaro's losses in municipal elections and the Centrão's gains left the fate of the 2021 budget and Guedes's economic agenda hanging on a second round still to come.
Monday morning in Brazil's financial markets opened with rates falling across the board, longer-dated contracts showing the steepest declines. The catalyst was thousands of miles away: Moderna had announced its experimental COVID-19 vaccine showed 94.5% efficacy in phase three trials. The news moved through global markets instantly — stock exchanges climbed, the dollar weakened, and in São Paulo, traders watched the yield curve flatten.
By 9:08 a.m., the numbers were clear. The January 2022 DI futures contract fell to 3.290% from Friday's 3.345%. The January 2027 contract slid from 7.46% to 7.34%. The pattern — shorter-term rates moving less, longer-term rates moving more — reflected what traders call desinclinação, an unwinding of the curve's steepness. A weaker dollar eased pressure on Brazil's external accounts, better global sentiment reduced demand for safety, and a vaccine that appeared to work meant the world might eventually return to something resembling normal.
Not everything pointed in the same direction. Brazil's IGP-10 inflation gauge for early November came in at 3.51%, above the median forecast of 3.33%. It wasn't enough to rattle markets — the vaccine news was too large — but wholesale price increases were being watched carefully for signs they might eventually reach consumers.
Later that morning, Central Bank president Roberto Campos Neto was scheduled to speak to the press, officially about PIX, Brazil's new instant payment system. Unofficially, the market was listening for any signal on inflation, fiscal risks, and the government's plans once emergency aid payments ended. The Focus survey showed inflation expectations ticking up slightly for both 2020 and 2021, while the Selic rate forecast held steady at 2% by year-end and 2.75% by end of 2021 — a market pricing in modest inflation without a rate response, at least for now.
Underlying it all was a political reality traders couldn't ignore. Bolsonaro had lost ground in Sunday's municipal elections while the centrist Centrão bloc emerged stronger — a dynamic that would shape Finance Minister Paulo Guedes's ability to pass the 2021 budget and advance his economic agenda. With a second round of voting still ahead, serious legislative work remained on hold. For the moment, the market was watching the vaccine, watching the dollar, watching the curve. Everything else could wait.
Monday morning in Brazil's financial markets opened with a familiar pattern: rates falling across the board, longer-dated contracts showing the steepest drops. The real was strengthening against the dollar, a shift driven by something happening thousands of miles away in a pharmaceutical lab. Moderna had just announced that its experimental COVID-19 vaccine showed 94.5% efficacy in phase three trials. The news rippled through global markets instantly. Stock exchanges climbed. The dollar weakened. And in São Paulo, traders watched the curve flatten.
By 9:08 a.m., the numbers told the story clearly. The January 2022 interest rate futures contract—the DI, as it's known locally—had fallen to 3.290% from Friday's close of 3.345%. The January 2023 contract dropped to 4.86% from 4.94%. Further out the curve, January 2025 fell to 6.60% from 6.70%, and January 2027 slid to 7.34% from 7.46%. The pattern was consistent: shorter-term rates moved less, longer-term rates moved more, a flattening that reflected what traders call desinclinação—a technical unwinding of the curve's steepness that had been building for days.
The mechanics were straightforward. A weaker dollar meant less pressure on Brazil's external accounts. Better global sentiment meant less demand for safety. And a vaccine that actually worked—or appeared to—meant the world might eventually return to something resembling normal economic activity. All of this pointed toward lower interest rates ahead, which is why the longer contracts, the ones that price in where rates might be in 2025 or 2027, were falling hardest.
But the morning brought complications too. Brazil's inflation gauge for early November, the IGP-10, came in at 3.51%, above the median forecast of 3.33%. It wasn't enough to move markets—the vaccine news was too big—but it was being watched. Wholesale prices were climbing, and traders were monitoring whether those increases would eventually show up in retail prices that consumers actually pay. That transmission mechanism, as economists call it, remained a live concern.
Later that morning, Central Bank president Roberto Campos Neto was scheduled to speak to the press. Officially, the topic was PIX, Brazil's new instant payment system. Unofficially, the market was waiting to hear what he might say about inflation, about fiscal risks, about the government's plans for a new microfinance program once emergency aid payments ended. These weren't abstract concerns. They were the things that would shape where interest rates actually went in the months ahead.
The Focus survey—the Central Bank's weekly compilation of market forecasts—had shifted slightly. Inflation expectations for 2020 had ticked up from 3.20% to 3.25%. For 2021, the forecast rose from 3.17% to 3.22%. But the Selic rate, Brazil's benchmark interest rate, remained unchanged in the survey: 2% annually by year-end 2020, and 2.75% by the end of 2021. The market, in other words, was pricing in a world where inflation rose a bit but rates stayed put—at least for now.
Underlying all of this was a political reality that traders couldn't ignore. President Jair Bolsonaro had lost ground in Sunday's municipal elections, but the bloc of centrist congressmen known as the Centrão had emerged stronger. This mattered because Paulo Guedes, the finance minister, needed those votes to pass the 2021 budget and advance his economic agenda. The second round of voting was still ahead, and serious legislative work was expected only after that. For now, the market was watching the vaccine news, watching the dollar, watching the curve flatten. Everything else could wait.
Notable Quotes
Market expectations for 2021 inflation rose from 3.17% to 3.22%, but Selic rate forecasts remained unchanged at 2.75% annually— Central Bank Focus survey
The Hearth Conversation Another angle on the story
Why did a vaccine announcement in the United States move Brazilian interest rates?
Because it changed how traders think about the future. A working vaccine means the world eventually reopens, which means less economic uncertainty, which means less need for high interest rates to compensate for risk. The real strengthened because global money started flowing back into riskier assets.
But Brazil's inflation numbers came in hot that morning. Shouldn't that have pushed rates up?
It should have, in theory. But the vaccine news was too big. One data point doesn't override a fundamental shift in global sentiment. That said, traders were definitely watching—they know inflation can become a real problem if wholesale prices keep climbing.
What's the significance of the curve flattening? Why do longer-term rates fall more than short-term ones?
It's about expectations. Short-term rates are already set by current conditions. But longer-term rates reflect where traders think rates will be in 2025 or 2027. If they think the world is reopening and inflation stays contained, they expect rates to stay low for years. That's why the 2027 contract fell more than the 2022 one.
Why does the Central Bank president's speech matter if it's officially about a payment system?
Because markets read between the lines. Campos Neto could signal whether the Central Bank is worried about inflation or fiscal risks. Those signals shape expectations for the Selic rate, which shapes everything else. A few careful words can move billions in trading.
And the political situation—the Centrão gaining strength—how does that affect markets?
It means the government's economic agenda depends on keeping those centrist votes happy. If the budget doesn't pass, if reforms stall, that's fiscal uncertainty. Markets hate uncertainty. But for now, the second round of elections hasn't happened yet, so it's a background concern, not an immediate one.
So what's the market actually expecting to happen next?
Rates probably stay low in the near term, especially if the vaccine news holds and global sentiment stays positive. But inflation is a watch item. If those wholesale prices start showing up in what consumers pay, the Central Bank might have to raise rates despite the vaccine optimism. That's the tension the market is sitting with.